CDKN2A and melanoma: Melanoma oncogenesis is, finally, an effect of many other mutations in different genes, including TP53, PTEN and CDKN2A, and also in the telomerase gene promoter and p16 [1], as malignant melanomas are genetically highly heterogeneous, and they acquire numerous mutations when metastasizing [11].